Accelerating Antibody Development with Automated Octet Assays
White Paper Mar 11, 2019
Drug development and production is challenging, however, high throughput characterization systems can greatly accelerate discovery programs.
Using a proprietary discovery and development platform technology, Avitide enables its partners to rapidly advance candidate molecules to the clinic and achieve faster and more predictable bioprocess development timelines.
Download this whitepaper to discover the key considerations for automated Octet assays.
Related White Papers
Download this whitepaper to discover the current research trends across the seven hallmarks of cancer, and how live-cell analysis is enhancing our understanding of the biological mechanisms underlying cancer behaviors.
READ MOREDownload this case study from Amgen to discover the challenges faced by their high throughput biologics team, how LIMS accelerated the generation of large molecule therapeutics, and much more.
READ MOREDownload this whitepaper to discover how to perform multiplexed screening, how to evaluate lead candidates, and much more!
READ MORELike what you just read? You can find similar content on the communities below.
Biopharma Cell Science DiagnosticsTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE
